Product Information
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G is a generic product labeled by Oceanside Pharmaceuticals, priced at $77.4610 per EA under NDC 68682020175. Its NADAC has been published 255 times since Nov 18, 2020.
FDA first approved this application on Aug 2, 2006. Its Orange Book therapeutic-equivalence code is AA.
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G
polyethylene glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic AcidManufacturer
Oceanside PharmaceuticalsNDC
68682020175
Classification
Generic
Dosage Form
KIT
Effective Date
9/17/2025
Approval Type
New Drug (NDA)
FDA Application
NDA021881FDA Approved
8/2/2006
TE Code
AA
On Market Since
10/1/2006
Price Statistics
The NADAC for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G has been published 255 times since Nov 18, 2020, and over the history we have for it it has declined 12.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $77.4610 per EA |
|---|---|
| All-time high | $91.4380 (Jan 12, 2022) |
| All-time low | $52.1485 (Jul 17, 2024) |
| 52-week high | $78.6065 |
| 52-week low | $77.4610 |
| Median price | $78.6065 |
| Average price | $79.0588 |
| Largest weekly change | -33.1% (Jul 17, 2024) |
| Weeks tracked | 255 |
| Tracking since | Nov 18, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-1.5%
3Y
+4.1%
5Y
-14.0%
All
-12.3%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the polyethylene glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
The current National Average Drug Acquisition Cost (NADAC) for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G, manufactured by Oceanside Pharmaceuticals, is $77.4610 per EA (NDC 68682020175), effective Oct 1, 2025.
How has the price of PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G changed over time?
Over the history we have for it, the NADAC for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G has declined 12.3%. It has been tracked across 255 weekly CMS publications since Nov 18, 2020.
What are the highest and lowest recorded NADAC prices for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
Since Nov 18, 2020, the NADAC for PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G has ranged from a low of $52.1485 (Jul 17, 2024) to a high of $91.4380 (Jan 12, 2022), with a median of $78.6065 per EA.
Are there cheaper alternatives to PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
No other NADAC-published product currently shares the active ingredient and strength of PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G?
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G (NDC 68682020175) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.